Comments
Laurus Labs has `successfully’ completed the maiden US Food and Drug Administration (USFDA) audit for its Unit-4 without any observations and no form 483 was issued.
The inspection was carried out from July 8-12 this year , the Hyderabad-based company said in a release here on Friday.
The Unit-4 of Laurus Labs, located at Achutapuram SEZ, Visakhapatnam, is meant for manufacturing of Active Pharma Ingredients.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.